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  Quercetin  3-O-β-(2"-galloyl)-rhamnopyranoside  (QGR) 
is  a  naturally  occurring  quercitrin  gallate,  which  is  a 
polyphenolic compound that was originally isolated from 
Persicaria lapathifolia (Polygonaceae). QGR has been shown 
to have an inhibitory effect on nitric oxide (NO) production in 
lipopolysaccharide (LPS)-stimulated macrophage RAW 264.7 
cells.  Therefore, this  study was conducted to investigate 
the inhibitory effect of QGR on nitric oxide production 
and inducible nitric oxide synthases (iNOS) expression in 
LPS-stimulated Balb/c mice. To accomplish this, 10 mg/kg 
of  QGR  was  administered  via  gavage  once  a  day  for  3 
days. iNOS was then induced by intraperitoneal injection 
of  LPS.  Six  hours  after  the  LPS  treatment  the  animals 
were sacrificed under ether anethesia. The serum levels of 
NO were then measured to determine if QGR exerted an 
inhibitory effect on NO production in vivo. LPS induced 
an approximately 6 fold increase in the expression of NO. 
However,  oral administration  of  QGR  reduced  the  LPS 
induced  increase  in  NO  by  half.  Furthermore,  RT-PCR 
and  western  blot  analysis  revealed  that  the  increased 
levels  of  iNOS  expression  that  occurred  in  response  to 
treatment  with  LPS  were  significantly  attenuated  in 
response to QGR pretreatment. Histologically, LPS induced 
the infiltration of polymorphonuclear neutrophils in portal 
veins and sinusoids and caused the formation of a large 
number of necrotic cells; however, pretreatment with QGR 
a t t e n u a t e d  t h e s e  L P S  i n d u c e d  e f f e c t s .  T a k e n  t o g e t h e r ,  
these results indicate that QGR inhibits iNOS expression 
in  vivo  as  well  as  in  vitro a n d  h a s  a n t i i n f l a m m a t o r y  
potentials.
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Introduction 
    Nitric oxide (NO) is an important intracelluar and 
intercellular signaling molecule that is involved in 
regulation of physiological and pathological mechanisms in 
cardiovascular, nervous and immune systems. NO plays many 
roles in living organisms, including regulation of muscle 
tone in vascular systems and acting as a biological mediator 
that functions in a fashion similar to neurotransmitters in 
the nervous system. In addition, NO is an important host 
defense effector molecule in the immune system [2]. 
Conversely, NO can also act as a cytotoxic agent in 
pathological processes [4].
  At physiological concentrations, NO inhibits proinflammatory 
platelet aggregation, integrin-mediated adhesion, and 
proinflammation induced gene expression, which are all 
factors that control vascular inflammation and oxidative 
injury. However, at high concentrations, NO and NO2
- can 
exert pathogenic properties due to the production of a more 
toxic metabolite, peroxinitrite (ONOO
-), which causes a 
reversal of the positive effects of NO [7].
    NO is generated by the conversion of L-arginine to 
L-citruline in the presence of the family of nitric oxide 
synthases (NOSs). Three isoforms of NOS have been found 
in various cell types. Both endothelial NOS and neuronal 
NOS are constitutive isoforms that play housekeeping roles by 
producing physiological concentrations of NO. Conversely, 
inducible NOS (iNOS) has the potential to synthesize high 
concentrations of NO during inflammatory processes in 
various types of cells such as endothelial cells, hepatocytes, 
monocytes, mast cells, macrophages and smooth muscle 
cells that have been stimulated by cytokines or bacterial 
products [28]. 
  Expression of the iNOS gene in macrophages is under the 
control of several transcription factors, including nuclear 
factor (NF)-κB [29]. NF-κB is functional as a hetero- or 
homo-dimeric form of proteins in the Rel family, such as 
RelA (p65), RelB, cRel, p50 and p52 and is sequestered in 
the cytoplasm by binding to IκB proteins such as IκBα, 268    Hyun-Ye Jo et al.
Fig. 1. Chemical structure of Quercetin 3-O-β-(2"-galloyl) 
rhamnopyranoside. 
IκBβ, IκBε, p105 and p100. Lipopolysaccharide (LPS) is a 
major component of the outer membranes of Gram-negative 
bacteria that can trigger a variety of inflammatory reactions 
by binding to its specific receptor, Toll-like receptor 4 [1]. 
Signalling components downstream of the receptor, in turn, 
activate the IκB kinase (IKK) complex [12]. Activation of 
the IKK complex results in phosphorylation of IκB, which 
masks its signal and results in ubiquitination, ultimately 
leading to proteasome-mediated degradation [19,25]. IκB 
degradation then unmasks the nuclear localization signal 
motif of NF-κB, which allows the transcription factor to 
move into the nucleus where it binds to the promoter region 
of immune and inflammatory genes such as iNOS, thereby 
regulating transcription [8,26]. 
  Quercetin 3-O-β-(2"-galloyl)-rhamnopyranoside (QGR) 
is a naturally occurring quercitrin gallate (Fig. 1), which is 
a polyphenolic compound that was originally isolated from 
Persicaria lapathifolia. It has been reported that QGR inhibits 
the iNOS expression induced by LPS treatment in macrophage 
RAW 264.7 cells by inhibiting nuclear translocation of 
NF-κB [14]. However, it is not known if QGR inhibits 
iNOS expression and NO production in vivo. Therefore, 
we conducted this study to determine if QGR exerts an 
inhibitory effect on iNOS expression and NO production 
induced by LPS treatment in Balb/c mice. 
Materials and Methods
Reagents 
  LPS (E. coli O55:B5) was purchased from Sigma-Aldrich 
(USA). The sequences of primer pairs for iNOS and GAPDH 
were synthesized by Bioneer (Korea). The other commercially 
purchased reagents were as follows: RNAiso reagent and a 
primeScript 1st strand cDNA synthesis kit from TaKaRa 
(Japan), Pro-prep and Pro-measure from iNtRON Biotechnology 
(Korea), anti-iNOS IgG from Santa Cruz Biotechnology 
(USA), anti-β-actin IgG and anti-rabbit IgG from Cell 
Signaling Technology (USA), polyvinylidene difluoride 
membrane from Millipore (USA). QGR (purity, > 98%) 
was isolated from P. lapathifolia [14].
Animal experiment 
  Seven week-old male Balb/c mice were purchased from 
Daehan Biolink (Korea). All animals were maintained under 
constant environmental conditions (temperature: 21-24
oC, 
relative humidity: 35-65%, 12-h light/12-h dark cycle). All 
animal experiments were performed in accordance with an 
interim guideline approved by the Institutional Animal Care 
and Use Committee of the Laboratory Animal Research 
Center in Chungbuk National University. 
  A total of 15 mice were randomly divided into 3 groups. 
Mice in group 1 were treated with vehicle as a control, 
mice in group 2 were treated with LPS (10 mg/kg) 
intraperitonially as a treatment control and mice in group 3 
were treated with QGR and LPS. QGR was administered to 
the mice once a day for 3 days at a dose of 10 mg/kg by 
gavage prior to LPS treatment. Six hours after LPS 
injection the mice were sacrificed under ether anesthesia.
Measurement of NO concentration 
  After being sacrificed, the blood was collected from the 
abdominal vein and then centrifuged at 3,000 rpm for 20 
min to obtain the serum. To measure the NO in the serum, 
100 μl of serum was mixed with the same volume of Griess 
reagent (1% sulfanilamide in 5% phosphoric acid and 
0.1% naphthylethylenediamine dihydrochloride in water) 
and then incubated for 10 min at room temperature. The 
optical densities were then measured at 540 nm using an 
ELISA reader (V-MAX 220 VAC; Molecular Devices, 
USA). 
Reverse transcription-polymerase chain reaction 
  Total RNA was extracted from the livers of the mice using 
an RNAiso reagent kit according to the manufacturer’s 
guides. Five μg of the total RNA were then used for reverse 
transcription to generate cDNA using a cDNA synthesis 
kit. The cDNA was then used as a template for PCR reactions 
with primers specific for iNOS or GAPDH. The sequences 
of the primers used to amplify iNOS were 5'-CCTCCTCC 
ACCCTACCAAGT-3' and 5'-CACCCAAAGTGCTTCA 
GTCA-3' (Gene Bank Accession No. NM010927), and the 
sequences of the primers used to amplify GADPH were 
5'-AACGGATTTGGTCGTATTGG-3' and 5'-AGCCTTC 
TCCATGGTGGTGAAGAC-3' (Gene Bank Accession No. 
NM017008). Each cDNA was amplified by subjecting the 
reaction mixture to the following conditions: 35 cycles of 
denaturation at 95
oC for 30 sec, annealing at 60
oC for 30 
sec, and extension at 72
oC for 1 min. The amplified cDNA 
was then separated on 1.5% agarose gels and visualized by 
staining with ethidium bromide. The relative intensities of 
the iNOS bands were then normalized to the corresponding Inhibition of iNOS expression by quercitrin gallate in vivo    269
Fig. 2. Effect of Quercetin 3-O-β-(2"-galloyl) rhamnopyranoside (QGR)
on nitric oxide (NO) production in serum. Lipopolysaccharide 
(LPS) induced an approximately 6 fold increase in NO when 
compared to controls. Pretreatment of QGR attenuated approximately
50% of the LPS induced increase in NO. *Significantly different
from control (p ＜ 0.05). 
Fig. 3. RT-PCR analysis of inducible nitric oxide synthases (iNOS)
mRNA in liver samples. A shows representative bands from each
group. B shows the normalized densitometric ratios of iNOS to 
GAPDH. Pretreatment with Quercetin 3-O-β-(2"-galloyl) 
rhamnopyranoside (QGR) significantly inhibited the iNOS mRNA
expression that was induced by lipopolysaccharide (LPS). 
*Significantly different from control (p ＜ 0.05), 
‡Significantly 
different from LPS treatment (p ＜ 0.05).
GAPDH band intensities. The results were then analyzed 
using the Quantity One program (Gel Doc EQ; Bio-Rad, 
USA).
Western blot analysis 
  Total protein was extracted from the livers of mice using 
a Pro-prep kit according to the manufacturer’s guides 
(iNtRON Biotechnology, Korea). One-hundred μg of protein 
were then denatured by boiling at 95
oC for 5 min in sample 
buffer (0.5 M Tris-HCl, pH 6.8, 10% sodium dodecyl 
sulfate (SDS), 0.36% glycerol, 0.06% 2-ME and 12% 
bromophenol blue). The samples were then separated by 
electrophoresis on 7.5% SDS-polyvinylamide minigels, after 
which they were transferred to polyvinylidene difluoride 
membranes in solution (25 mM Tris, 192 mM glycine in 
20% methanol, pH 8.3). Next, the samples were blocked 
for 1 hr with 5% skim milk in Tris-buffered saline Tween 20 
(TBST, 25 mM Tris, 150 mM NaCl, 0.05% Tween 20), after 
which the membranes were incubated overnight with 1：250 
dilutions of rabbit anti-murine iNOS polyclonal antibody 
or 1：1,000 dilutions of rabbit anti-β-actin polyclonal 
antibody at 4
oC. The membranes were then washed with 
TBST, after which they were incubated for 1 h with 1：
1,000 dilutions of goat anti-rabbit IgG conjugated with 
horseradish peroxidase at room temperature. The relative 
intensities of the iNOS bands were then normalized to the 
corresponding β-actin band intensities. The films were 
then scanned and analyzed using the Quantity One program 
(Gel Doc EQ; Bio-Rad, USA). 
Histopathology 
  Liver tissues were fixed with 10% phosphate buffered 
formalin and then processed following routine histological 
techniques. After paraffin embedment, 4 μm sections were 
stained with hematoxylin and eosin and then subjected to 
histopathologic evaluation. The histological changes were 
quantitatively analyzed using an index of the severity of tissue 
injury. The index was based on neutrophil infiltration, 
which was determined by counting the polymorphonuclear 
neutrophils (PMN) in 10 randomly selected high-power 
fields (×400). The index was expressed as the mean ± SD. 
Statistical analysis 
  All data were analyzed by one-way ANOVA and Dunnett's 
t-test using SPSS v 12.0K. For all comparisons, a  p  <  0.05 
was considered to be statistically significant. 
Results
Effect of QGR on NO production in serum 
  As shown in Fig. 2, the concentration of NO significantly 
increased from 10 μM to 60 μM in response to treatment 
with LPS. However, pretreatment with QGR inhibited the 
increase in NO that was induced by LPS by approximately 50%.
Effect of QGR on iNOS mRNA expression in 
the liver 
  As shown in Fig. 3, the expression of iNOS mRNA was 270    Hyun-Ye Jo et al.
Fig. 4. Western blot analysis of inducible nitric oxide synthases 
(iNOS) protein in liver samples. A shows representative bands 
from each group. B shows normalized densitometric ratios of 
iNOS to β-actin. Pretreatment with Quercetin 3-O-β-(2"-galloyl)
rhamnopyranoside (QGR) inhibited the iNOS protein expression that
was induced by LPS. *Significantly different from control (p＜0.05).
Fig. 5. Effect of Quercetin 3-O-β-(2"-galloyl) rhamnopyranoside
(QGR) on polymorphonuclear neutrophil (PMN) infiltration in 
the liver. A, B: control; C, D: lipopolysaccharide (LPS) treatment;
E, F: QGR + LPS treatment. A, C, E: ×200; B, D, F: ×400. Arrows
indicate the infiltration of PMN.
Fig. 6. The number of polymorphonuclear neutrophils (PMN) in
liver samples. The number of PMN in 10 randomly selected 
high-power fields. Lipopolysaccharide (LPS) induced an obvious
increase in the infiltration of PMN, but this increase was attenuated
by pretreatment with Quercetin 3-O-β-(2"-galloyl) rhamnopyranoside
(QGR). *Significantly different from control (p＜0.05), 
‡Significantly
different from LPS treatment (p ＜ 0.05).
approximately 77% of that of the expression of GAPDH in 
control cells. However, the expression of iNOS mRNA 
increased to 103% of that of the expression of GAPDH in 
control cells in response to treatment with LPS. When mice 
were pretreated with QGR, the expression of iNOS mRNA 
in the LPS group was 83% of that of the expression of 
GAPDH in the control group. 
Effect of QGR on iNOS protein expression in the 
liver 
  As shown in Fig. 4, the level of iNOS protein expression 
in control cells was approximately 25% of that of the expression 
of β-actin in the controls. In addition, iNOS protein expression 
in LPS treated mice increased to 80% of that of the expression 
of β-actin in the controls. However, pretreatment with QGR 
inhibited the increased expression of iNOS protein that 
was induced by LPS to 50% of the expression of β-actin.
Effect of QGR on PMN infiltration in the liver 
  To evaluate the histological changes in response to treatment, 
tissue slides were made from liver samples. Almost no 
infiltration of PMN was observed in the livers of mice that 
were subjected to the control treatment. However, there 
was obvious infiltration of PMN in the portal veins and 
sinusoids of livers from mice that were treated with LPS 
(Fig. 5). In addition, many necrotic cells were observed in 
some areas of the livers of LPS treated mice. Pretreatment 
with QGR significantly decreased the number of infiltrated 
PMN and necrotic cells in the livers of mice that were 
treated with LPS (Fig. 6). 
Discussion 
  NO has both protective and destructive effects on biological 
features. It acts as a neurotransmitter and is an important 
host defense effector, as well as a regulator of blood 
pressure [2]. Conversely, it has a free radical structure and 
acts as a cytotoxic agent in pathological processes [4]. 
  Many types of cells express iNOS as part of the host 
defense against bacterial, parasitic and viral pathogens [5]. 
This expression leads to the formation of NO radicals and Inhibition of iNOS expression by quercitrin gallate in vivo    271
its reaction products, S-nitrosothiols or ONOO
-, in the host 
cells or the invading microbe itself. iNOS expression in 
macrophages is activated by particular inducers, after 
which it participates in the pathology of inflammatory 
diseases such as atherosclerosis, rheumatoid arthritis, 
diabetes, septic shock, and cell death [6,10]. Accordingly, 
several reports have shown that iNOS inhibitors ease the 
symptoms of arthritis, ulcerative colitis and autoimmune 
diseases [24].  
  Inhibition  of  NF-κB activation is considered to be 
important when designing iNOS inhibitors because NF-κB 
activation is the primary regulatory step involved in iNOS 
expression [3,5]. Recently, a large number of substances 
derived from plants have been evaluated to determine if 
they could inhibit the NF-κB pathway. These substances 
include lignans such as manassantins and saucernetin [22], 
sesquiterpenes such as celastrol [16], costunolide and 
celaohanol [13], diterpenes such as excisanin and kamebakaurin 
[11], triterpenes such as avicin [19] and oleandrin [20], and 
polyphenols such as resveratrol [18], epigallocatechin gallate 
[17] and quercetin [27]. 
  QGR is a naturally occurring quercitrin gallate, which is 
a polyphenolic compound that was originally isolated from 
Persicaria lapathifolia (Polygonacease) [14]. It has been 
reported that QGR inhibits NADPH oxidase complex-mediated 
superoxide production in unopsonized zymosan-stimulated 
human monocytes through its weak ability to scavenge oxygen 
/nitrogen radical species such as superoxide and NO [15]. 
In addition, QGR has been reported to inhibit iNOS expression 
induced by LPS treatment in macrophage RAW 264.7 cells 
by inhibiting nuclear translocation of NF-κB [14].
  Quercetin is an aglycone of QGR that has been reported to 
inhibit LPS-dependent production of iNOS mRNA and to 
decrease the release of NO in macrophage RAW 264.7 
cells [21]. In addition, quercetin has been shown to exert 
anti-inflammatory effects by acting on IKK complex as a 
mixed type of inhibitor, which suggests that its bindings site 
overlaps both the ATP and IκBα binding pockets on the 
enzyme [23]. However, since QGR does not inhibit 
LPS-mediated IκBα phosphorylation, the effects of QGR on 
LPS-mediated NF-κB activation must function through a 
different inhibitory mechanism from its aglycone, quercetin 
[14].
  In the present study, we demonstrated that QGR suppressed 
iNOS mRNA and protein expression in the liver and reduced 
the serum NO concentration of mice that were challenged 
by LPS. In addition, we found that QGR attenuated the 
infiltration of PMN and hepatocytic necrosis. Taken together, 
these results indicate that QGR exerts its antiinflammatory 
activity by inhibiting the iNOS-NO pathway, and that it has 
therapeutic potential for the treatment of a wide range of 
inflammatory diseases. 
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